Niagen Bioscience, Inc. (NAGE), a promising player in the biotechnology sector, is capturing investor interest with its significant growth potential. With a market capitalization of $406.21 million, Niagen is strategically positioned in the healthcare sector, focusing on the development of healthy aging products. The company, headquartered in Los Angeles, California, operates through three key segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services.

Currently trading at $5.09, Niagen’s stock has experienced a wide 52-week range between $5.09 and $14.41. Despite recent stagnation with no price change, the company boasts a remarkable revenue growth rate of 32.90%, a testament to its robust…